|
Triplets versus doublets in the treatment of right-sided metastatic colorectal cancer in real-world setting: A propensity-score weighting analysis. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Ipsen |
|
|
No Relationships to Disclose |
|
|
Employment - Grupo Oncoclinicas |
Stock and Other Ownership Interests - Grupo Oncoclinicas; Johnson & Johnson |
Honoraria - Grupo Oncoclinicas |
Consulting or Advisory Role - SERVIER |
Speakers' Bureau - SERVIER |
Research Funding - Amgen; Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - AstraZeneca |
|
|
Employment - Grupo Oncoclínicas; Rede D'Or São Luiz |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Grupo Oncoclinicas |
Stock and Other Ownership Interests - Grupo Oncoclinicas |
Honoraria - Grupo Oncoclinicas |
|
|
Employment - Oncoclínicas |
Stock and Other Ownership Interests - Trialing Health |
Consulting or Advisory Role - Boehringer Ingelheim; Foundation Medicine; Roche |
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; Ipsen; Libbs; Lilly; MSD Oncology; Roche; Sanofi; SERVIER |
|
|
|
Employment - Grupo Oncoclinicas |
Stock and Other Ownership Interests - Grupo Oncoclinicas |
Honoraria - Grupo Oncoclinicas |
Consulting or Advisory Role - Astellas Oncology; Lilly |
Speakers' Bureau - Bayer; Merck; SERVIER |
|
|
Consulting or Advisory Role - Lilly; SERVIER |
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; BMS Brazil; Roche; SERVIER; SERVIER |
Research Funding - Bayer (Inst) |
Travel, Accommodations, Expenses - Ipsen |